Photodynamic therapy with 5-Aminolevulinic acid (ALA) impairs tumor initiating and chemo-resistance property in head and neck cancer-derived cancer stem cells

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Yu, Chuan Hang ^a,b   Yu, Cheng Chia ^a,b  

^a CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID; CISPLATIN; FLUOROURACIL; HERMES ANTIGEN; ISOENZYME; OCTAMER TRANSCRIPTION FACTOR 4; PROTEIN ALDH1; TRANSCRIPTION FACTOR NANOG; UNCLASSIFIED DRUG; ALDEHYDE DEHYDROGENASE ISOENZYME 1; CD44 PROTEIN, HUMAN; HOMEODOMAIN PROTEIN; NANOG PROTEIN, HUMAN; PHOTOSENSITIZING AGENT; POU5F1 PROTEIN, HUMAN; RADIOSENSITIZING AGENT; RETINAL DEHYDROGENASE; TUMOR MARKER;

ARTICLE; CANCER ADJUVANT THERAPY; CANCER INHIBITION; CANCER RESISTANCE; CANCER STEM CELL; CELL INVASION; CELL RENEWAL; CHEMOSENSITIZATION; CONTROLLED STUDY; DRUG EFFICACY; DRUG POTENTIATION; ENZYME ACTIVITY; ENZYME INHIBITION; HEAD AND NECK CANCER; HUMAN; HUMAN CELL; PHOTODYNAMIC THERAPY; PROTEIN EXPRESSION; TUMOR INVASION; ANTAGONISTS AND INHIBITORS; CELL TRANSFORMATION; DRUG EFFECTS; DRUG RESISTANCE; GENE EXPRESSION REGULATION; GENETICS; HEAD AND NECK NEOPLASMS; METABOLISM; PATHOLOGY; PHOTOCHEMOTHERAPY; PRIMARY CELL CULTURE; TUMOR CELL LINE;

AMINOLEVULINIC ACID; ANTIGENS, CD44; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; CISPLATIN; DRUG RESISTANCE, NEOPLASM; DRUG SYNERGISM; GENE EXPRESSION REGULATION, NEOPLASTIC; HEAD AND NECK NEOPLASMS; HOMEODOMAIN PROTEINS; HUMANS; ISOENZYMES; NEOPLASTIC STEM CELLS; OCTAMER TRANSCRIPTION FACTOR-3; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PRIMARY CELL CULTURE; RADIATION-SENSITIZING AGENTS; RETINAL DEHYDROGENASE; TUMOR MARKERS, BIOLOGICAL;

EID: 84899864894     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0087129     Document Type: Article

References (30)

1. Siegel R, Naishadham D, Jemal A (2013) Cancer statistics, 2013. CA Cancer J Clin 63: 11-30.
2. Hu FW, Tsai LL, Yu CH, Chen PN, Chou MY, et al. (2012) Impairment of tumor-initiating stem-like property and reversal of epithelial-mesenchymal transdifferentiation in head and neck cancer by resveratrol treatment. Mol Nutr Food Res 56: 1247-1258.
3. Yu CC, Tsai LL, Wang ML, Yu CH, Lo WL, et al. (2013) miR145 targets the SOX9/ADAM17 axis to inhibit tumor-initiating cells and IL-6-mediated paracrine effects in head and neck cancer. Cancer Res 73: 3425-3440.
4. Wu MJ, Jan CI, Tsay YG, Yu YH, Huang CY, et al. (2010) Elimination of head and neck cancer initiating cells through targeting glucose regulated protein78 signaling. Mol Cancer 9: 283.
5. Prince ME, Sivanandan R, Kaczorowski A, Wolf GT, Kaplan MJ, et al. (2007) Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc Natl Acad Sci U S A 104: 973-978. (Pubitemid 46154721)
6. Yu CC, Chen YW, Chiou GY, Tsai LL, Huang PI, et al. (2011) MicroRNA let-7a represses chemoresistance and tumourigenicity in head and neck cancer via stem-like properties ablation. Oral Oncol 47: 202-210.
7. Chen YW, Chen KH, Huang PI, Chen YC, Chiou GY, et al. (2010) Cucurbitacin I suppressed stem-like property and enhanced radiation-induced apoptosis in head and neck squamous carcinoma-derived CD44(+)ALDH1(+) cells. Mol Cancer Ther 9: 2879-2892.
8. Green B, Cobb AR, Hopper C (2013) Photodynamic therapy in the management of lesions of the head and neck. Br J Oral Maxillofac Surg 51: 283-287.
9. Dolmans DE, Fukumura D, Jain RK (2003) Photodynamic therapy for cancer. Nat Rev Cancer 3: 380-387. (Pubitemid 37328858)
10. Chen HM, Chen CT, Yang H, Kuo MY, Kuo YS, et al. (2004) Successful treatment of oral verrucous hyperplasia with topical 5-aminolevulinic acid-mediated photodynamic therapy. Oral Oncol 40: 630-637. (Pubitemid 38452683)
11. Chen HM, Yu CH, Tu PC, Yeh CY, Tsai T, et al. (2005) Successful treatment of oral verrucous hyperplasia and oral leukoplakia with topical 5-aminolevulinic acid-mediated photodynamic therapy. Lasers Surg Med 37: 114-122. (Pubitemid 41266294)
12. Yu CH, Chen HM, Hung HY, Cheng SJ, Tsai T, et al. (2008) Photodynamic therapy outcome for oral verrucous hyperplasia depends on the clinical appearance, size, color, epithelial dysplasia, and surface keratin thickness of the lesion. Oral Oncol 44: 595-600.
13. Yu CH, Chen HM, Lin HP, Chiang CP (2013) Expression of Bak and Bak/Mcl-1 ratio can predict photodynamic therapy outcome for oral verrucous hyperplasia and leukoplakia. J Oral Pathol Med 42: 257-262.
14. Lou PJ, Jager HR, Jones L, Theodossy T, Bown SG, et al. (2004) Interstitial photodynamic therapy as salvage treatment for recurrent head and neck cancer. Br J Cancer 91: 441-446. (Pubitemid 39093561)
15. Lisnjak IO, Kutsenok VV, Polyschuk LZ, Gorobets OB, Gamaleia NF (2005) Effect of photodynamic therapy on tumor angiogenesis and metastasis in mice bearing Lewis lung carcinoma. Exp Oncol 27: 333-335. (Pubitemid 43139368)
16. Chen HM, Liu CM, Yang H, Chou HY, Chiang CP, et al. (2011) 5-aminolevulinic acid induce apoptosis via NF-kappaB/JNK pathway in human oral cancer Ca9-22 cells. J Oral Pathol Med 40: 483-489.
17. Yang TH, Chen CT, Wang CP, Lou PJ (2007) Photodynamic therapy suppresses the migration and invasion of head and neck cancer cells in vitro. Oral Oncol 43: 358-365.
18. Lo WL, Yu CC, Chiou GY, Chen YW, Huang PI, et al. (2011) MicroRNA-200c attenuates tumour growth and metastasis of presumptive head and neck squamous cell carcinoma stem cells. J Pathol 223: 482-495.
19. Chiou SH, Yu CC, Huang CY, Lin SC, Liu CJ, et al. (2008) Positive correlations of Oct-4 and Nanog in oral cancer stem-like cells and high-grade oral squamous cell carcinoma. Clin Cancer Res 14: 4085-4095.
20. Yu CC, Lo WL, Chen YW, Huang PI, Hsu HS, et al. (2011) Bmi-1 Regulates Snail Expression and Promotes Metastasis Ability in Head and Neck Squamous Cancer-Derived ALDH1 Positive Cells. J Oncol 2011.
21. Chen YC, Chang CJ, Hsu HS, Chen YW, Tai LK, et al. (2010) Inhibition of tumorigenicity and enhancement of radiochemosensitivity in head and neck squamous cell cancer-derived ALDH1-positive cells by knockdown of Bmi-1. Oral Oncol 46: 158-165.
22. Lo JF, Yu CC, Chiou SH, Huang CY, Jan CI, et al. (2011) The epithelial-mesenchymal transition mediator S100A4 maintains cancer-initiating cells in head and neck cancers. Cancer Res 71: 1912-1923.
23. Visvader JE, Lindeman GJ (2008) Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat Rev Cancer 8: 755-768.
24. Korkaya H, Wicha MS (2010) Cancer stem cells: nature versus nurture. Nat Cell Biol 12: 419-421.
25. Polyak K, Weinberg RA (2009) Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat Rev Cancer 9: 265-273.
26. Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, et al. (2008) The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133: 704-715. (Pubitemid 351636299)
27. Chiou SH, Wang ML, Chou YT, Chen CJ, Hong CF, et al. (2010) Coexpression of Oct4 and Nanog enhances malignancy in lung adenocarcinoma by inducing cancer stem cell-like properties and epithelial-mesenchymal transdifferentiation. Cancer Res 70: 10433-10444.
28. Yang MH, Wu MZ, Chiou SH, Chen PM, Chang SY, et al. (2008) Direct regulation of TWIST by HIF-1alpha promotes metastasis. Nat Cell Biol 10: 295-305.
29. Haddad RI, Shin DM (2008) Recent advances in head and neck cancer. N Engl J Med 359: 1143-1154.
30. Clarke MF, Dick JE, Dirks PB, Eaves CJ, Jamieson CH, et al. (2006) Cancer stem cells-perspectives on current status and future directions: AACR Workshop on cancer stem cells. Cancer Res 66: 9339-9344.